- Home
- MCRI vs SRPT Comparison
MCRI vs SRPT Comparison
Compare MCRI & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRI
- SRPT
- Stock Information
- Founded
- MCRI 1972
- SRPT 1980
- Country
- MCRI United States
- SRPT United States
- Employees
- MCRI N/A
- SRPT N/A
- Industry
- MCRI Hotels/Resorts
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- MCRI Consumer Discretionary
- SRPT Health Care
- Exchange
- MCRI Nasdaq
- SRPT Nasdaq
- Market Cap
- MCRI 1.9B
- SRPT 2.0B
- IPO Year
- MCRI 1993
- SRPT 1997
- Fundamental
- Price
- MCRI $104.33
- SRPT $18.20
- Analyst Decision
- MCRI Hold
- SRPT Hold
- Analyst Count
- MCRI 5
- SRPT 30
- Target Price
- MCRI $96.20
- SRPT $44.37
- AVG Volume (30 Days)
- MCRI 78.8K
- SRPT 10.7M
- Earning Date
- MCRI 10-22-2025
- SRPT 08-06-2025
- Dividend Yield
- MCRI 1.15%
- SRPT N/A
- EPS Growth
- MCRI N/A
- SRPT N/A
- EPS
- MCRI 4.22
- SRPT N/A
- Revenue
- MCRI $534,693,999.00
- SRPT $2,481,531,000.00
- Revenue This Year
- MCRI $6.80
- SRPT $9.41
- Revenue Next Year
- MCRI $4.13
- SRPT N/A
- P/E Ratio
- MCRI $24.75
- SRPT N/A
- Revenue Growth
- MCRI 4.65
- SRPT 64.89
- 52 Week Low
- MCRI $69.99
- SRPT $10.42
- 52 Week High
- MCRI $113.88
- SRPT $140.10
- Technical
- Relative Strength Index (RSI)
- MCRI 61.59
- SRPT 46.55
- Support Level
- MCRI $100.02
- SRPT $17.57
- Resistance Level
- MCRI $106.75
- SRPT $19.13
- Average True Range (ATR)
- MCRI 2.21
- SRPT 1.25
- MACD
- MCRI 0.09
- SRPT -0.07
- Stochastic Oscillator
- MCRI 75.68
- SRPT 13.94
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.